Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Page properties
Title

Psoriasis Area and Severity Index Version Feldman (PASI FELDMAN)

CDISC ReferenceClinical Classification Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials
QRS Short Name

PASI FELDMAN

QRS Permission StatusPublic Domain
TeamPsoriasis Standards Team and CDISC Questionnaires, Ratings, and Scales (QRS) Subteam
Supplement Version1.0
StatusDRAFT
Date2022-0607-3024
Notes
  • This supplement is intended to be used with other CDISC user guides for specific therapeutic/disease areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical Trials.
Known Issue(s)
  • Version 1 of the Psoriasis Area and Severity Index CDISC Controlled Terminology (RSCAT=PASI with synonym=PASI01) is scheduled for deprecation and an associated QRS supplement will not be released.
  • There is not general agreement between industry, regulators, and academia on a standard set of responses for the PASI. Therefore, CDISC has created separate terminology and supplements for multiple references with different sets of responses for the PASI. This supplement uses the Feldman reference as the standard for responses.

...

Revision History

DateVersion
2022-0607-30241.0 Draft

© 2022 Clinical Data Interchange Standards Consortium, Inc. All rights reserved. 

1 Introduction

This document describes the CDISC implementation of the Psoriasis Area and Severity Index Version Feldman (PASI FELDMAN) instrument. Note that Version 1 of the CDISC Controlled Terminology is scheduled for deprecation and an associated CDISC Version 1 instrument and SDTMIG QRS supplement were never released.

...

The CDISC Intellectual Property Policy can be found on the CDISC website at: https://www.cdisc.org/about/bylaws.

1.1 Representations and Warranties, Limitations of Liability, and Disclaimers

This document is a supplement to the SDTMIG for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material.

...

Although the United States Food and Drug Administration (US FDA) has provided input with regard to this supplement, this input does not constitute US FDA endorsement of any particular instrument.

2 Copyright Status

CDISC believes this instrument to be in the public domain, but you should perform your own assessment. CDISC has included the PASI V2in the CDISC library of QRS data standards supplements. Hence, CDISC developed RSTESTCD and RSTEST for each item based on the actual text on the instrument. There may be many versions of this instrument. CDISC has chosen to use this version as the data standard.

...

  • Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(Suppl 2):ii65–ii68.
  • CDISC believes this instrument to be in the public domain, but you should perform your own assessment.


3 The RS Domain Model

3.1 Assumptions for the RS Domain Model

All assumptions and business rules described in the SDTMIG RS domain are applicable to this supplement. Additional assumptions specific to the PASI FELDMAN are listed below.

...

  1. The scale points for the symptoms include a numeric rating (0-4) and a definition of what is represented by the rating (e.g., 0 = "None"). For the PASI FELDMAN, RSORRES is populated with the text description; the numeric rating is represented in the standardized character and numeric result variables RSSTRESC and RSSTRESN.

    1. CDISC created a CRF based on the Feldman article using the symptom terms "erythema/redness," , "thickness/induration," , and "desquamation/scaling." . Per subject-matter expert recommendations, desquamation was included with scaling even though desquamation is not referenced in the Feldman article.
  2. The scale points for the area include a numeric rating (0-6) and a definition of what is represented by the rating (e.g., 0 = "0 (clear)"). For the area, RSORRES is populated with the text description; the numeric rating is represented in the standardized character and numeric result variables RSSTRESC and RSSTRESN.
  3. The PASI FELDMAN instrument includes subscores and a total score that are considered as captured data on the CRF and are not considered as derived in the example below. These scores may be submitted in SDTM or derived in the Analysis Data Model (ADaM) per scoring instructions from the Feldman reference.

    1. If operationally defined by the sponsor, it is the sponsor's responsibility to set the --DRVFL flag based on their eCRF process to derive subtotals and total scores. An investigator-derived score will be considered a captured score and not flagged. When subtotal and total scores are derived by the sponsor, the derived flag (--DRVFL) is set to "Y". However, when the subtotal and total scores are received from a central provider or vendor, the value would go into --ORRES and --DRVFL would be null (see SDTMIG Section 4.1.8.1, Origin Metadata for Variables).

    2. If scores are received by the sponsor, it is recommended that they are submitted to SDTM and verified in ADaM.

  4. Records are created in rs.xpt for every item on the instrument

    1. For items with no data, RSORRES, RSSTRESC, and RSSTRESN are all missing and RSSTAT = "NOT DONE".  If the reason is known, that reason is represented in RSREASND (e.g., RSREASND = "REFUSED"). If the reason is unknown, RSSTAT = "NOT DONE" and RSREASND is missing.

  5. Terminology

    1. RSCAT, RSTESTCD, and RSTEST values are included in CDISC Controlled Terminology.

    2. A full list of value sets for the result field is provided in Section 4, SDTM Mapping Strategy.

3.2 Example for the PASI FELDMAN RS Domain Model

The PASI FELDMAN example below shows the terminology used to implement the instrument in the RS domain. The example uses CDISC Controlled Terminology for RSTESTCD, RSTEST, and RSCAT. All original results, matching the CRF item response text, are represented in RSORRES. This result is then represented as a standard numeric score in RSSTRESN and as a standard character representation in RSSTRESC.

...

Dataset wrap
Namers
Rowcaps
Rows 1-16:Show the symptom and area responses for the baseline visit.
Rows 17-29:Show the subscores and total scores for the baseline visit.
Rows 30-59:Show the subject was not evaluated on this instrument at visit 2. Since the reason for not completing the visit was collected, the date is included in RSDTC for when the visit was planned.
Dataset2
RowSTUDYIDDOMAINUSUBJIDRSSEQRSTESTCDRSTESTRSCATRSORRESRSSTRESCRSSTRESNRSSTATRSREASNDRSLOBXFLVISITNUMRSDTC
1STUDYXRS2324-P00011PASI0201PASI02-Head: Erythema/Redness
PASI FELDMANSlight11

Y12015-05-15
2STUDYXRS2324-P00012PASI0202PASI02-Head: Thickness/Induration
PASI FELDMANNone00

Y12015-05-15
3STUDYXRS2324-P00013PASI0203PASI02-Head: Desquamation/Scaling
PASI FELDMANNone00

Y12015-05-15
4STUDYXRS2324-P00014PASI0204PASI02-Head: Area Score
PASI FELDMAN<10%11

Y12015-05-15
5STUDYXRS2324-P00015PASI0205PASI02-Up Extrem: Erythema/Redness
PASI FELDMANMild22

Y12015-05-15
6STUDYXRS2324-P00016PASI0206PASI02-Up Extrem: Thickness/Induration
PASI FELDMANSlight11

Y12015-05-15
7STUDYXRS2324-P00017PASI0207PASI02-Up Extrem: Desquamation/Scaling
PASI FELDMANMild22

Y12015-05-15
8STUDYXRS2324-P00018PASI0208PASI02-Up Extrem: Area Score
PASI FELDMAN30 - <50%33

Y12015-05-15
9STUDYXRS2324-P00019PASI0209PASI02-Trunk: Erythema/Redness
PASI FELDMANNone00

Y12015-05-15
10STUDYXRS2324-P000110PASI0210PASI02-Trunk: Thickness/Induration
PASI FELDMANNone00

Y12015-05-15
11STUDYXRS2324-P000111PASI0211PASI02-Trunk: Desquamation/Scaling
PASI FELDMANNone00

Y12015-05-15
12STUDYXRS2324-P000112PASI0212PASI02-Trunk: Area Score
PASI FELDMAN0 (clear)00

Y12015-05-15
13STUDYXRS2324-P000113PASI0213PASI02-Low Extrem: Erythema/Redness
PASI FELDMANSlight11

Y12015-05-15
14STUDYXRS2324-P000114PASI0214PASI02-Low Extrem: Thickness/Induration
PASI FELDMANSlight11

Y12015-05-15
15STUDYXRS2324-P000115PASI0215PASI02-Low Extrem: Desquamation/Scaling
PASI FELDMANSlight11

Y12015-05-15
16STUDYXRS2324-P000116PASI0216PASI02-Low Extrem: Area Score
PASI FELDMAN10 - <30%22

Y12015-05-15
17STUDYXRS2324-P000117PASI0217PASI02-Head: Sum of Symptom Scores
PASI FELDMAN111

Y12015-05-15
18STUDYXRS2324-P000118PASI0218PASI02-Head: Sum X Area
PASI FELDMAN111

Y12015-05-15
19STUDYXRS2324-P000119PASI0219PASI02-Head: Sum X Area X 0.1
PASI FELDMAN0.10.10.1

Y12015-05-15
20STUDYXRS2324-P000120PASI0220PASI02-Up Extrem: Sum of Symptom Scores
PASI FELDMAN555

Y12015-05-15
21STUDYXRS2324-P000121PASI0221PASI02-Up Extrem: Sum X Area
PASI FELDMAN151515

Y12015-05-15
22STUDYXRS2324-P000122PASI0222PASI02-Up Extrem: Sum X Area X 0.2
PASI FELDMAN333

Y12015-05-15
23STUDYXRS2324-P000123PASI0223PASI02-Trunk: Sum of Symptom Scores
PASI FELDMAN000

Y12015-05-15
24STUDYXRS2324-P000124PASI0224PASI02-Trunk: Sum X Area
PASI FELDMAN000

Y12015-05-15
25STUDYXRS2324-P000125PASI0225PASI02-Trunk: Sum X Area X 0.3
PASI FELDMAN000

Y12015-05-15
26STUDYXRS2324-P000126PASI0226PASI02-Low Extrem: Sum of Symptom Scores
PASI FELDMAN333

Y12015-05-15
27STUDYXRS2324-P000127PASI0227PASI02-Low Extrem: Sum X Area
PASI FELDMAN666

Y12015-05-15
28STUDYXRS2324-P000128PASI0228PASI02-Low Extrem: Sum X Area X 0.4
PASI FELDMAN2.42.42.4

Y12015-05-15
29STUDYXRS2324-P000129PASI0229PASI02-Total Sum
PASI FELDMAN5.55.55.5

Y12015-05-15
30STUDYXRS2324-P000130PASI0201PASI02-Head: Erythema/Redness
PASI FELDMAN


NOT DONEREFUSED
22015-06-14
31STUDYXRS2324-P000131PASI0202PASI02-Head: Thickness/Induration
PASI FELDMAN


NOT DONEREFUSED
22015-06-14
32STUDYXRS2324-P000132PASI0203PASI02-Head: Desquamation/Scaling
PASI FELDMAN


NOT DONEREFUSED
22015-06-14
...














59STUDYXRS2324-P000159PASI0229PASI02-Total Sum
PASI FELDMAN


NOT DONEREFUSED
22015-06-14


4 SDTM Mapping Strategy

This section is used for reference regarding the CRF data capture and to understand the alignment of the instrument to the SDTM RS domain. It also provides guidance on how the result variables (RSORRES, RSSTRESC, and RSSTRESN) should be populated.

...